Georgetown University Medical Center

A new clinical research opportunity for people diagnosed with Huntington’s disease (HD) who are experiencing the early symptoms of the disease has launched at Georgetown University Medical Center. The INVEST-HD international study is a Phase 3 research study evaluating an investigational oral medication called votoplam. The goal of this 24-36 month study is to see if this treatment can help slow the progression of HD symptoms. People between the ages of 21 and 70 and have a previous genetic diagnosis for Huntington’s disease may be eligible. Participants will be compensated for their time and effort. Learn more about the trial and how to schedule a screening visit at https://medicine.georgetown.edu/news-releases/georgetown-university-opens-advanced-study-for-huntingtons-disease/

Huntington's Disease Clinical Trial - School of Medicine - Georgetown Georgetown University Medical Center has launched a new clinical research opportunity for people diagnosed with Huntington’s disease.

Young Georgetown Alumni Are Among the Highest-Paid Graduates in the Country - Georgetown University Georgetown early-career alumni are among the highest-paid college graduates in the nation, according to data from the U.S. Department of Education.